CompletedPhase 2NCT00349453

Study Using Deferiprone Alone or in Combination With Desferrioxamine in Iron Overloaded Transfusion-dependent Patients

Studying Hereditary Hemochromatosis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Lipomed
Principal Investigator: Petrign FG Töndury, MD, LCSW
Intervention: Deferiprone (L1)(drug)
Enrollment: 24 enrolled
Eligibility: 4 years · All sexes
Timeline: 2005 – 2011

Study locations (13)

Cantonal Hospital, Children's Clinic, Aarau, Canton of Aargau, Switzerland
Cantonal Hospital, Aarau, Canton of Aargau, Switzerland
Private children's practice, Bern, Canton of Bern, Switzerland
Children's Hospital of Eastern Switzerland, Sankt Gallen, Canton of St. Gallen, Switzerland
University Children's Hospital, Zurich, Canton of Zurich, Switzerland
University Hospital, Zurich, Canton of Zurich, Switzerland
Private practice, Zürich (Kreis 11) / Oerlikon, Canton of Zurich, Switzerland
Private practice, Arzo, Canton Ticino, Switzerland
Private practice, Lugano, Canton Ticino, Switzerland
Regional Hospital, Lugano, Canton Ticino, Switzerland
Private practice, Riva San Vitale, Canton Ticino, Switzerland
Cantonal Hospital Graubünden, Chur, Kanton Graubünden, Switzerland
Private children's practice, Brig, Valais, Switzerland

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00349453 on ClinicalTrials.gov

← Back to all trials